INVESTINGSanofi and GlaxoSmithKline Get $2.1 Billion to Develop Covid-19 VaccineBy M. Corey GoldmanJul 31, 2020 11:01 AM EDT
VideoCoronavirus Update: What Merck, Chevron, Colgate-Palmolive, Caterpillar Said About the PandemicJul 31, 2020 8:39 AM EDT
INVESTINGSanofi and GlaxoSmithKline Get $2.1 Billion to Develop Covid-19 VaccineBy M. Corey GoldmanJul 31, 2020 11:01 AM EDT
PRESS RELEASESAcerus Announces Addition Of Chief Medical OfficerBy Business WireJul 21, 2020 7:30 AM EDT
INVESTING5 Stock Gainers for Friday: VBI Vaccines, Moderna, NovavaxBy Rob LenihanJul 17, 2020 4:23 PM EDT
INVESTINGPrincipia Biopharma Soars as Sanofi Is Said to Seek DealsBy Rob LenihanJul 16, 2020 3:52 PM EDT
PRESS RELEASESKymera Therapeutics And Sanofi Enter Into Strategic Partnership To Advance Novel Protein Degrader Therapies To PatientsBy PR NewswireJul 9, 2020 7:00 AM EDT
INVESTINGRegeneron Starts Late-Stage Trials of Coronavirus CocktailBy Rob LenihanJul 6, 2020 8:35 AM EDT
INVESTINGTranslate Bio Joins With Sanofi to Make Covid-19 VaccinesBy Dan WeilJun 23, 2020 10:38 AM EDT
INVESTINGRoche and Gilead Sciences Testing Two-Drug Covid-19 ComboBy M. Corey GoldmanMay 28, 2020 10:53 AM EDT
INVESTINGSanofi Selling Long-Standing Stake in Regeneron for $13 BillionBy M. Corey GoldmanMay 26, 2020 6:54 AM EDT
INVESTINGFrance Says Sanofi Plan to Put US First For COVID Vaccine 'Unacceptable'By Martin BaccardaxMay 14, 2020 9:54 AM EDT
INVESTINGSanofi CEO Says U.S. Entitled to First Delivery of Coronavirus VaccineBy Dan WeilMay 13, 2020 10:44 AM EDT
INVESTINGRegeneron to Begin Human Studies of Covid-19 Treatment in JuneBy M. Corey GoldmanMay 5, 2020 3:31 PM EDT
INVESTINGRegeneron and Sanofi Drug Shows Promise Treating Sickest Coronavirus PatientsBy M. Corey GoldmanApr 27, 2020 9:33 AM EDT
INVESTINGThe Dow Disconnect: Cramer's 'Mad Money' Recap (Tuesday 4/14/20)By Scott RuttApr 14, 2020 9:14 PM EDT
PRESS RELEASESSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Sanofi - SNYBy PR NewswireApr 12, 2020 2:32 PM EDT
INVESTINGFDA Asks Sanofi to Pull Zantac From the Market, Citing Cancer RiskBy Annie GausApr 1, 2020 4:51 PM EDT
HEALTHCoronavirus Latest Updates: A Timeline of Recent EventsBy Steve FiorilloMar 30, 2020 12:05 PM EDT
INVESTINGRegeneron, Sanofi Enroll First Person Outside of U.S. in Coronavirus Treatment TestBy Tony OwusuMar 30, 2020 9:04 AM EDT
JIM CRAMERMarket Turning Point?: Cramer's 'Mad Money' Recap (Friday 3/27/20)By Scott RuttMar 27, 2020 8:43 PM EDT
INVESTINGRegeneron Launches US Trials for Coronavirus Treatment With France's SanofiBy Martin BaccardaxMar 16, 2020 11:16 AM EDT
